Timothy P Kelly Net Worth & Insider Trades

Timothy P Kelly - Chief Operating Officer, Homology Medicines, Inc

As of February 28, 2022

What is Timothy P Kelly's Net Worth?

The current estimated net worth of Homology Medicines, Inc's Chief Operating Officer, Timothy P Kelly, is estimated to be about $184.26K . Timothy P Kelly owns about 2,224 units of Homology Medicines, Inc common stock. In the last 4 years at Homology Medicines, Inc, Timothy P Kelly has sold an estimated value of $180.3K worth.

What is Timothy P Kelly's Past Insider Trading?

Timothy P Kelly's largest purchase order was 10,232 units , worth over $88.62K on March 3, 2021. Timothy P Kelly's largest sale order was 4,000 units , worth over $49.46K on February 3, 2021. In total, Timothy P Kelly has made about 15 transactions over 4 years of their time at Homology Medicines, Inc. Timothy P Kelly usually trades in February, with the busiest year in 2021. The most recent transaction was a sale order of 1,406 units , worth over $5.31K on January 12, 2022.

Timothy P Kelly

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Timothy P Kelly's' Mailing Address?

  • Mailing address is C/o Homology Medicines, Inc. One Patriots Park Bedford MA 01730 MA

Homology Medicines, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Arthur O. Tzianabos, Ph.D. 2020 $563,200 - - $309,760 $13,000 $885,960
Arthur O. Tzianabos, Ph.D. 2019 $537,600 - $4,217,097 $295,680 $12,500 $5,062,877
Albert Seymour, Ph.D. 2020 $426,800 - - $170,720 $10,057 $607,577
Albert Seymour, Ph.D. 2019 $405,600 - $1,295,756 $162,240 $13,231 $1,876,827
W. Bradford Smith 2020 $406,700 - - $162,680 $13,000 $582,380
W. Bradford Smith 2019 $384,200 - $1,307,536 $153,680 $14,880 $1,860,296
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1661998/000156459021021931/fixx-def14a_20210617.htm

What are Homology Medicines, Inc's Past Insider Trades?

Homology Medicines, Inc's most recent insider trade came on January 12, 2022 by W. Bradford Smith who sold 2,182 units worth $8.25K . In the last 4 years, insiders at Homology Medicines, Inc have sold an estimated value of $109.51M and bought an estimated value of $60.18M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Albert Seymour, See remarks,  Timothy P Kelly, Chief Operating Officer,  and Arthur Tzianabos, President & CEO .

Homology Medicines, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1